FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/08/2022
Voltar para busca
Dado oficial do USPTO
QUANTIVAC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
16/08/2022
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
29/01/2021
Data de registro
08/02/2022
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/02/2022
Última transação
08/02/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
DE
Examinador
HOLTZ, ALLISON
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EUROIMMUN Medizinische Labordiagnostika AG
Representantes
Kevan L. Morgan Seed IP Law Group LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations and diagnostic substances for scientific purposesin particular immobilised proteinsnucleic acidsallergens and tissue sections on a carrier/a carrier materialin particular a biochipmicrospherepaper ringtest stripblotmicrotiter plate or membrane
Classe 5
Diagnostic preparationsin particular diagnostic preparations for medical and veterinary purposes for the detection of allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseasesfood intolerancescancer; diagnostic preparations for medical and veterinary purposes; diagnostic preparations for medical and veterinary purposesin particular immobilised proteinsnucleic acidsallergens and tissue sections on a carrier/a carrier materialin particular a biochipmicrospheretest stripblotmicrotiter plate or membrane; reagents for medical and veterinary diagnostic purposes; reagents for medical and veterinary diagnosisin particular immobilised proteinsnucleic acidsallergens and tissuesections on a carrier/a carrier materialin particular a biochipmicrospherepaper ringtest stripblotmicrotiter plate or membrane
Classe 9
Measuringdetecting and monitoring instrumentsmeasuringdetecting and monitoringdevicesmeasuringdetecting and monitoring regulators for preparingprocessing and evaluating diagnostic samples for detecting allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseasesfood intolerances and cancer; Sensors and detectorsin particular UV fluorescence and chemiluminescence detectors for preparingprocessing and evaluating diagnostic samples; Apparatus for recordingtransmitting or reproducing diagnostic datasound or imagesin particular camerasmicroscopesphotometersmicroplate photometersenzyme-linked immunosorbent assay readerschemiluminescence readersphotomultipliersmicroplate readers; Downloadablerecorded or preinstalled softwarein particular downloadablerecorded or preinstalled laboratory software for analyzing laboratory test results
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
16/07/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
16/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
06/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/11/2021
PUBO
PUBLISHED FOR OPPOSITION
23/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/11/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/10/2021
RFNT
REFUSAL PROCESSED BY IB
11/09/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/08/2021
RFRR
REFUSAL PROCESSED BY MPU
23/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/08/2021
CNRT
NON-FINAL ACTION WRITTEN
19/08/2021
DOCK
ASSIGNED TO EXAMINER
19/08/2021
MAFR
APPLICATION FILING RECEIPT MAILED
25/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QUANTIVAC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.